Tissue diagnostic market forecast points to $11.97 billion by 2030

The tissue diagnostic market is projected to grow from $6.38 billion in 2025 to $7.25 billion in 2026, then reach $11.97 billion by 2030, according to The Business Research Company. Rising cancer cases, AI-assisted pathology, and digital healthcare investment are among the main forces shaping demand.

Why it matters: - Tissue diagnostics help clinicians detect abnormalities in tissue samples and support diagnosis under regulatory frameworks. - Faster growth in cancer incidence is increasing demand for pathology tools, reagents, and automated diagnostic systems. - The market outlook signals continued investment in precision diagnostics and digital pathology infrastructure.

What happened: - The Business Research Company published its Tissue Diagnostic Global Market Report 2026, covering market size, trends, and forecasts through 2035. - The global tissue diagnostic market is projected to rise from $6.38 billion in 2025 to $7.25 billion in 2026, a 13.6% CAGR. - The market is forecast to reach $11.97 billion by 2030, at a 13.4% CAGR. - North America held the largest share of the tissue diagnostic market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa. - Download a free sample of the report. - View the full tissue diagnostic market report.

The details: - Historical growth was driven by higher cancer diagnostics volumes, more pathology labs in hospitals, wider adoption of immunohistochemistry, greater use of automated diagnostic tools, and improved access to advanced reagents. - Expected growth drivers include rising demand for precision diagnostics, broader use of AI-assisted pathology tools, expanding personalized medicine programs, and more investment in digital healthcare infrastructure. - The forecast period also points to a stronger focus on diagnostic accuracy and shorter turnaround times. - Emerging trends include digital pathology platforms, automated tissue staining systems, AI-based image analysis, multiplex tissue assays, and standardized workflows. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, and updated graphics and tables.

Between the lines: - The report links market growth to both disease burden and lab modernization, which suggests demand is coming from clinical need and workflow efficiency at the same time. - The emphasis on AI, digital pathology, and automation points to a market shifting from manual processing toward software-enabled diagnostics. - WHO forecast in February 2024 projected more than 35 million new cancer cases by 2050, up 77% from 20 million in 2022, reinforcing the long-term demand case.

What's next: - The market is expected to continue expanding as precision medicine programs and digital diagnostic tools spread. - Adoption of AI-based image analysis and automated staining systems is likely to accelerate during the forecast period. - Additional regional competition may intensify as hospitals and labs invest in faster, more accurate tissue testing.

The bottom line: - Tissue diagnostics is moving from a supporting lab function to a core growth area in cancer care and precision medicine.